Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 355

1.

Selection and evaluation of an efficient method for the recovery of viral nucleic acid extraction from complex biologicals.

Sathiamoorthy S, Malott RJ, Gisonni-Lex L, Ng SHS.

NPJ Vaccines. 2018 Aug 10;3:31. doi: 10.1038/s41541-018-0067-3. eCollection 2018.

2.

Therapeutic Vaccines for Genitourinary Malignancies.

Dutcher GMA, Bilen MA.

Vaccines (Basel). 2018 Aug 12;6(3). pii: E55. doi: 10.3390/vaccines6030055. Review.

3.

Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis.

Thadi A, Khalili M, Morano WF, Richard SD, Katz SC, Bowne WB.

Vaccines (Basel). 2018 Aug 10;6(3). pii: E54. doi: 10.3390/vaccines6030054. Review.

4.

The Vestigial Esterase Domain of Haemagglutinin of H5N1 Avian Influenza A Virus: Antigenicity and Contribution to Viral Pathogenesis.

Zheng Z, Paul SS, Mo X, Yuan YA, Tan YJ.

Vaccines (Basel). 2018 Aug 10;6(3). pii: E53. doi: 10.3390/vaccines6030053. Review.

5.

Next Generation Cancer Vaccines-Make It Personal!

Terbuch A, Lopez J.

Vaccines (Basel). 2018 Aug 9;6(3). pii: E52. doi: 10.3390/vaccines6030052. Review.

6.

Cytokines IL-17, TNF and IFN-γ Alter the Expression of Antimicrobial Peptides and Proteins Disparately: A Targeted Proteomics Analysis using SOMAscan Technology.

Altieri A, Piyadasa H, Recksiedler B, Spicer V, Mookherjee N.

Vaccines (Basel). 2018 Aug 7;6(3). pii: E51. doi: 10.3390/vaccines6030051.

7.

Induction of neutralizing antibody response against koala retrovirus (KoRV) and reduction in viral load in koalas following vaccination with recombinant KoRV envelope protein.

Olagoke O, Miller D, Hemmatzadeh F, Stephenson T, Fabijan J, Hutt P, Finch S, Speight N, Timms P.

NPJ Vaccines. 2018 Aug 2;3:30. doi: 10.1038/s41541-018-0066-4. eCollection 2018.

8.

Activation-induced Markers Detect Vaccine-Specific CD4⁺ T Cell Responses Not Measured by Assays Conventionally Used in Clinical Trials.

Bowyer G, Rampling T, Powlson J, Morter R, Wright D, Hill AVS, Ewer KJ.

Vaccines (Basel). 2018 Jul 31;6(3). pii: E50. doi: 10.3390/vaccines6030050.

9.

Incorporation of NS1 and prM/M are important to confer effective protection of adenovirus-vectored Zika virus vaccine carrying E protein.

Liu X, Qu L, Ye X, Yi C, Zheng X, Hao M, Su W, Yao Z, Chen P, Zhang S, Feng Y, Wang Q, Yan Q, Li P, Li H, Li F, Pan W, Niu X, Xu R, Feng L, Chen L.

NPJ Vaccines. 2018 Jul 24;3:29. doi: 10.1038/s41541-018-0072-6. eCollection 2018.

10.

Contribution of Host Defence Proteins and Peptides to Host-Microbiota Interactions in Chronic Inflammatory Lung Diseases.

van der Does AM, Amatngalim GD, Keijser B, Hiemstra PS, Villenave R.

Vaccines (Basel). 2018 Jul 28;6(3). pii: E49. doi: 10.3390/vaccines6030049. Review.

11.

Listeria monocytogenes as a Vector for Cancer Immunotherapy: Current Understanding and Progress.

Flickinger JC Jr, Rodeck U, Snook AE.

Vaccines (Basel). 2018 Jul 25;6(3). pii: E48. doi: 10.3390/vaccines6030048. Review.

12.
13.

Avian Influenza A Virus Pandemic Preparedness and Vaccine Development.

de Vries RD, Herfst S, Richard M.

Vaccines (Basel). 2018 Jul 25;6(3). pii: E46. doi: 10.3390/vaccines6030046. Review.

14.

Why Is Eradicating Typhoid Fever So Challenging: Implications for Vaccine and Therapeutic Design.

Yang YA, Chong A, Song J.

Vaccines (Basel). 2018 Jul 24;6(3). pii: E45. doi: 10.3390/vaccines6030045. Review.

15.

Effects of LL-37 on Gingival Fibroblasts: A Role in Periodontal Tissue Remodeling?

McCrudden MTC, O'Donnell K, Irwin CR, Lundy FT.

Vaccines (Basel). 2018 Jul 23;6(3). pii: E44. doi: 10.3390/vaccines6030044.

16.

Down-selection of the VAR2CSA DBL1-2 expressed in E. coli as a lead antigen for placental malaria vaccine development.

Chêne A, Gangnard S, Dechavanne C, Dechavanne S, Srivastava A, Tétard M, Hundt S, Leroy O, Havelange N, Viebig NK, Gamain B.

NPJ Vaccines. 2018 Jul 17;3:28. doi: 10.1038/s41541-018-0064-6. eCollection 2018.

17.

Methods for Measuring T-Cell Memory to Vaccination: From Mouse to Man.

Flaxman A, Ewer KJ.

Vaccines (Basel). 2018 Jul 21;6(3). pii: E43. doi: 10.3390/vaccines6030043. Review.

18.

Improved Induction of Anti-Melanoma T Cells by Adenovirus-5/3 Fiber Modification to Target Human DCs.

Chondronasiou D, Eisden TTHD, Stam AGM, Matthews QL, Icyuz M, Hooijberg E, Dmitriev I, Curiel DT, de Gruijl TD, van de Ven R.

Vaccines (Basel). 2018 Jul 18;6(3). pii: E42. doi: 10.3390/vaccines6030042.

19.

The Immunity Gap Challenge: Protection against a Recent Florida Clade 2 Equine Influenza Strain.

Paillot R, Garrett D, Lopez-Alvarez MR, Birand I, Montesso F, Horspool L.

Vaccines (Basel). 2018 Jul 2;6(3). pii: E38. doi: 10.3390/vaccines6030038.

20.

Interaction of Viral Capsid-Derived Virus-Like Particles (VLPs) with the Innate Immune System.

Mohsen MO, Gomes AC, Vogel M, Bachmann MF.

Vaccines (Basel). 2018 Jul 2;6(3). pii: E37. doi: 10.3390/vaccines6030037. Review.

Supplemental Content

Loading ...
Support Center